Intra Artherial Therapies in Treatment of Primary Liver Diseases: an Observational Study

Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY

The goal of this observational study is to learn what are the best conditions that will give a positive outcome to men and women that receive a intra arterial therapy (IAT) for primary liver cancer. Intra arterial therapies are radiologic procedures that block liver cancer blood supply. The researchers will collect the data of participants located in the Radiology department in IRCCS Azienda Ospedaliera Universitaria Hospital in Bologna and will study clinic and radiological traits to understand which is the best case scenario for a optimal treatment response.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
View:

• diagnosis of Hepatocellular carcinoma (HCC) or intrahepatic cholangiocarcinoma (iCCA) and clinical indication to receive or have already received one of the following treatments:

‣ Trans-arterial embolization (TAE),

⁃ Transarterial chemoembolization (TACE),

⁃ Transarterial radioembolization (TARE)

⁃ Drug-eluting beads chemoembolization (DEB-TACE)

• Age over 18

• To give informed consent

Locations
Other Locations
Italy
IRCCS Azienda Ospedaliero-Universitaria di Bologna
RECRUITING
Bologna
Contact Information
Primary
Cristina Mosconi, MD
cristina.mosconi@aosp.bo.it
0039 3498496325
Time Frame
Start Date: 2021-04-21
Estimated Completion Date: 2030-04
Participants
Target number of participants: 3300
Sponsors
Leads: IRCCS Azienda Ospedaliero-Universitaria di Bologna

This content was sourced from clinicaltrials.gov